| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/21/2004 | EP1409676A2 Cd109 nucleic acid molecules polypeptides and methods of use |
| 04/21/2004 | EP1409675A1 Gene involved in apoptosis regulation |
| 04/21/2004 | EP1409674A2 Human 7tm proteins and polynucleotides encoding them |
| 04/21/2004 | EP1409673A2 Human leucine-rich repeat containing protein, expressed predominantely in small intestine, hlrrsi1 |
| 04/21/2004 | EP1409672A2 Antisense oligonucleotides which can inhibit the formation of capillary tubes by endothelial cells |
| 04/21/2004 | EP1409670A2 Synthetic double stranded oligonucleotides for targeted inhibition of gene expression |
| 04/21/2004 | EP1409669A2 Root specific, stimulant inducible promoter and its use |
| 04/21/2004 | EP1409668A2 Antisense nucleic acid against alphav integrin |
| 04/21/2004 | EP1409667A2 Process for preparing variant polynucleotides |
| 04/21/2004 | EP1409666A2 Process for preparing variant polynucleotides |
| 04/21/2004 | EP1409665A2 Method to generate non virulent microorganisms from pathogenic ones trough permanent genetic modification of their biological membrane for vaccine production |
| 04/21/2004 | EP1409664A2 Yeast alpha-amylase promoter and uses thereof |
| 04/21/2004 | EP1409662A1 Allene oxide synthase and divinyl ether synthase from the cyp74-enzyme family isolated out of physcomitrella patens, the nucleotide sequences that code these synthases, and method for producing pathogen-resistant plants |
| 04/21/2004 | EP1409661A2 Hdac9 polypeptides and polynucleotides and uses thereof |
| 04/21/2004 | EP1409660A2 Crystal structure of beta-site app cleaving enzyme (bace) and use thereof |
| 04/21/2004 | EP1409659A2 Subtilase variants |
| 04/21/2004 | EP1409658A2 Aggrecanase molecules |
| 04/21/2004 | EP1409655A2 Immunoglobulin superfamily proteins |
| 04/21/2004 | EP1409652A2 Immortalized preosteoblasts and method for their production |
| 04/21/2004 | EP1409647A2 Composite scaffolds and methods using same for generating complex tissue grafts |
| 04/21/2004 | EP1409646A2 Transgenic animals comprising a humanized immune system |
| 04/21/2004 | EP1409641A2 Engineering fungi for the utilisation of l-arabinose |
| 04/21/2004 | EP1409639A1 Epidermal growth factor receptorantisense oligonucleotides |
| 04/21/2004 | EP1409638A2 Cell cycle nucleic acids, polypeptides and uses thereof |
| 04/21/2004 | EP1409550A1 Extracellular messengers |
| 04/21/2004 | EP1409549A2 Compositions and methods for the diagnosis and treatment of tumor |
| 04/21/2004 | EP1409548A2 Ligands to enhance cellular uptake of biomolecules |
| 04/21/2004 | EP1409547A2 Methods and pharmaceutical compositions for immune deception, particularly useful in the treatment of cancer |
| 04/21/2004 | EP1409545A2 Allelic variants of grp50 |
| 04/21/2004 | EP1409544A2 Human dr4 antibodies and uses thereof |
| 04/21/2004 | EP1409543A2 Isolated human receptor proteins, nucleic acid molecules encoding human receptors proteins, and uses thereof |
| 04/21/2004 | EP1409542A2 Blood group antigen fusion polypeptides and methods of use thereof |
| 04/21/2004 | EP1409541A2 A single-cell biosensor for the measurement of gpcr ligands in a test sample |
| 04/21/2004 | EP1409537A2 Identification of specific tumour antigens by means of the selection of cdna libraries with sera and the use of said antigens in diagnostic imaging techniques |
| 04/21/2004 | EP1409536A2 Human proteins and nucleic acids encoding same |
| 04/21/2004 | EP1409535A2 Human secreted proteins |
| 04/21/2004 | EP1409533A2 Recombinant plasmodium falciparum merozoite protein-1/42 vaccine |
| 04/21/2004 | EP1409532A2 Moringa seed proteins |
| 04/21/2004 | EP1409531A2 Heterocarpine, a human ghrh-binding protein |
| 04/21/2004 | EP1409527A1 Novel human cytomegalovirus (hcmv) cytotoxic t cell epitopes, polyepitopes, compositions comprising same and diagnostic and prophylactic and therapeutic uses therefor |
| 04/21/2004 | EP1409526A2 An inducer of apoptosis |
| 04/21/2004 | EP1409525A2 Human papillomavirus e2 transactivation domain/inhibitor co-crystal and x-ray coordinates defining the inhibitor-binding pocket |
| 04/21/2004 | EP1409523A2 Pancam nucleic acids and polypeptides |
| 04/21/2004 | EP1409517A2 Fusion proteins based upon somatostatin receptors |
| 04/21/2004 | EP1409514A1 Chimeric histone acetyltransferase polypeptides |
| 04/21/2004 | EP1409510A2 Biological pacemaker |
| 04/21/2004 | EP1409509A2 Antisense modulation of c-reactive protein expression |
| 04/21/2004 | EP1409507A2 Compositions, methods and kits relating to remodelin |
| 04/21/2004 | EP1409506A1 Methods and compositions for rnai mediated inhibition of gene expression in mammals |
| 04/21/2004 | EP1409456A2 Detection of transmembrane potentials by optical methods |
| 04/21/2004 | EP1409025A1 Vector encoding human globlin gene and use thereof in treatment of hemoglobinopathies |
| 04/21/2004 | EP1409016A2 Antibodies to opgl |
| 04/21/2004 | EP1409012A1 Methods of inducing a cytotoxic immune response and recombinant simian adenovirus compositions useful therein |
| 04/21/2004 | EP1409011A1 Prime-boost vaccination strategy |
| 04/21/2004 | EP1409008A1 Use of the disintegrin domain of an adamalysin as anti-angiogenic, anti-invasive and anti-metastatic agent |
| 04/21/2004 | EP1409005A1 Modulators of notch signalling for use in immunotherapy |
| 04/21/2004 | EP1409003A2 Methods for reducing immunogenicity of polypeptides |
| 04/21/2004 | EP1408996A2 A simplified and improved method for preparing an antibody or an antibody fragment targeted immunoliposome or polyplex for systemic administration of a therapeutic or diagnostic agent |
| 04/21/2004 | EP1408995A1 Modulating serum amyloid a interaction with tanis and agents useful for same |
| 04/21/2004 | EP1408909A2 Improved conditionally replicating vectors for inhibiting viral infections |
| 04/21/2004 | EP1408908A2 Compositions and methods for inhibition of cancer invasion and angiogenesis |
| 04/21/2004 | EP1408811A2 Methods of diagnosis of bladder cancer, compositions and methods of screening for modulators of bladder cancer |
| 04/21/2004 | EP1408808A2 Methods for diagnosing and treating heart disease |
| 04/21/2004 | EP1408737A2 Tagetes erecta marigolds with altered carotenoid compositions and ratios |
| 04/21/2004 | EP1408736A2 Plants characterized by enhanced growth and methods and nucleic acid constructs useful for generating same |
| 04/21/2004 | EP1339732A4 Specific double-stranded probes for homogeneous detection of nucleic acid and their application methods |
| 04/21/2004 | EP1252339B1 Synthesis of spatially addressed molecular arrays |
| 04/21/2004 | EP1242603B1 Vectors and method for producing recombinant proteins in fungi |
| 04/21/2004 | EP1232396B1 Assay of isomerised and/or optically inverted proteins |
| 04/21/2004 | EP1212331B1 28-epirapalogs |
| 04/21/2004 | EP1179184A4 Identifying material from a breast duct |
| 04/21/2004 | EP1135533B1 Method and system for detecting oligonucleotides in a sample |
| 04/21/2004 | EP1100310A4 Plants, seeds and oils having an elevated total monounsaturated fatty acid content |
| 04/21/2004 | EP1071701A4 Non-endogenous, constitutively activated human serotonin receptors and small molecule modulators thereof |
| 04/21/2004 | EP1053301B1 A universal immunomodulatory cytokine-expressing bystander cell line and related compositions and methods of manufacture and use |
| 04/21/2004 | EP1021559B1 Method and kit for amplification, sequencing and typing of classical hla class i genes |
| 04/21/2004 | EP0980378B1 Method for detecting the presence of biological matters of bovine origin, and oligonucleotides for its implementation |
| 04/21/2004 | EP0975796A4 Screen employing fluorescence anisotropy to identify compounds with affinity for nucleic acids |
| 04/21/2004 | EP0859847B1 Composition and method of imparting resistivity to hiv superinfection to cells |
| 04/21/2004 | EP0836647B1 Antiviral proteins, dna coding sequences therefor, and uses thereof |
| 04/21/2004 | EP0815263B1 Methods for the detection of clonal populations of transformed cells in a genomically heterogeneous cellular sample |
| 04/21/2004 | EP0815218B1 Human vegf-specific antisense oligonucleotides |
| 04/21/2004 | EP0714406B1 Refolding of polypeptides like recombinant insulin-like growth factor igf-i |
| 04/21/2004 | EP0641215B1 Protease-resistant thrombomodulin analogs |
| 04/21/2004 | CN1491283A Vector for introducing molecules in eukaryotic cells and molecules vectorized by same |
| 04/21/2004 | CN1491282A Process for producing prenyl alcohol |
| 04/21/2004 | CN1491281A Neurotonin and use thereof |
| 04/21/2004 | CN1491280A Synovial membrane cell protein |
| 04/21/2004 | CN1491278A Lipase variants |
| 04/21/2004 | CN1491232A Modified leptin with reduced immunogenicity |
| 04/21/2004 | CN1491231A Modified keratinocyte growth factor (KGF) with reduced immunogenicity |
| 04/21/2004 | CN1491116A Hepatitis B virus treatment |
| 04/21/2004 | CN1490410A High effective expression of recombined human internal inhibition factor |
| 04/21/2004 | CN1490409A Preparing method for recombinant chBJSTWO protein and use thereof |
| 04/21/2004 | CN1490408A Antihuman seminal specific protein P30 detection reagent strips and monoclone antibody therewith |
| 04/21/2004 | CN1490407A Antihuman hemoglobin detection reagent strips and monoclone antibody contained therewith |
| 04/21/2004 | CN1490406A Recombined human organ plasminogen activator streptokinase and its preparation |
| 04/21/2004 | CN1490357A Structural body containing polyhydroxy chain alkyl ester |
| 04/21/2004 | CN1490335A Method and application of expressions of sTNFR immuno desmolin fusion protein and polypeptide |
| 04/21/2004 | CN1490334A Affinity purifying method for gene specific antibody |